Home  |  Contact Us   |  Blog
Toll Free North America:
1 (866) 813-6354
Direct Line:
1 (613) 723-5757
Genetically modified crops have DNA from another organism inserted to give the crops properties like pest resistance.

The DNA Genotek Grant application period is now closed.

The application period for the DNA Genotek Grant Program is now closed. We thank everyone who submitted an application. The applications are currently being evaluated. We will announce the winner on March 7, 2012. Please check back often for information on the current grant program and future grant programs.

The DNA Genotek Grant Program

Information and Rules | Application Form

Terms and Conditions

  1. The applicant agrees that they have read, understood and agree to be bound by all of the DNA Genotek Grant Program Rules and by these Additional Terms and Conditions.
  2. By applying, the applicant represents and warrants that:
    a. They have obtained all required authorizations and permissions from their institution or company,
    b. They will not violate any of their institution's or company's rules, policies, or procedures by applying to this Grant Program,
    c. Their institution or company has agreed to be bound by all of the Grant Program Rules and by these Additional Terms and Conditions.
  3. DNA Genotek is not responsible for applicant's actions or decisions or those of their employees or agents.
  4. DNA Genotek reserves the right to discontinue or modify the Grant Program at any time and for any reason. In such event, DNA Genotek will post a notice on this website (www.dnagenotek.com/grant). In the event of discontinuation of the Grant Program, DNA Genotek will have no liability to any existing or possible applicant or applicant's employees or agents for such cancellation or modification.
  5. DNA Genotek may refuse to award the prize to any or all applicants if DNA Genotek determines at its sole discretion that the granting of such award would likely result in a violation of an applicable federal, state or local law, rule or policy.
  6. DNA Genotek will withhold the award until the winner has obtained all necessary IRB approvals.
  7. The successful applicant will own any intellectual property arising from the results that are free of any encumbrances stipulated in Section 10 of the Product Terms and Conditions, and may take such steps as it may decide from time to time, and at its own expense, to register and maintain any protection for that intellectual property, including filing and prosecuting patent applications for any of the results.
  8. The winner and their employees and agents hereby irrevocably authorize DNA Genotek to copy, exhibit, publish, and distribute images, audio, video and other works of every kind based upon the submission, oral discussions, and presentations, solely for DNA Genotek's marketing purposes. Applicant hereby releases and holds harmless DNA Genotek and forever discharges DNA Genotek from any and all claims, demands, and causes of action which may arise by reason of this authorization.
  9. Except expenses related to the Grant Winner's presentation of results at the ASHG Annual Meeting, each applicant is responsible for all of their own costs, and the costs of its employees and agents, that are incurred or that may be incurred in connection with this Grant Program, including, without limitation, any tax liability and any costs associated with entering into and participating in this Grant Program, developing ideas and materials, submitting materials, traveling and generally participating in the Grant Program.
  10. Applicant understands and agrees that no ideas, information, or materials that are submitted to or otherwise provided to DNA Genotek in connection with this Grant Program will be returned.
  11. Each applicant and their employees and agents agree to accept and abide by the Grant Program Rules and agrees that any dispute with regard to the conduct of the Grant Program, rule interpretation or the award of the prizes, shall be resolved by DNA Genotek, whose decision shall be binding and final. By participating, each applicant and their employees and agents agree to release and hold harmless DNA Genotek and all of its officers, directors, employees, agents and representatives, from any injury, loss or damage, including death or property damage, due in-whole or in-part, directly or indirectly to the acceptance, use, or misuse of a grant, participation in any Grant Program-related activity, or participation in the Grant Program. DNA Genotek is not responsible for any typographical or other error herein, administration of the Grant Program or in the announcement of the award, including such error as may give an erroneous indication that an award has been won.
  12. The funds awarded under this Grant Program may not be used for any purposes other than those described in the application form. DNA Genotek products awarded under this Grant Program may not be re-sold, or used for any other purposes other than that described in the Grant Program application. Unused DNA Genotek products must be returned upon completion of the project.
  13. IN NO EVENT SHALL DNA GENOTEK, ITS OFFICERS, DIRECTORS, EMPLOYEES, OR AGENTS, BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES WHATSOEVER ARISING UNDER OR AS A RESULT OF ENTRANCE IN OR PARTICIPATION IN THE GRANT PROGRAM, WHETHER BASED ON WARRANTY, CONTRACT, TORT, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT DNA GENOTEK IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, THE FOREGOING LIMITATION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW. THE TOTAL LIABILITY OF DNA GENOTEK ARISING UNDER OR RELATING TO THIS GRANT PROGRAM SHALL NOT EXCEED THE TOTAL VALUE OF THE PRIZE AWARDED TO THE SUCCESSFUL APPLICANT UNDER THIS GRANT PROGRAM.
  14. For the purpose of this Agreement, the term "Affiliate" shall mean any corporation or other business entity controlling, controlled by or under common control with a party; and for such purpose, "control" shall mean direct or indirect ownership of: i) fifty percent (50%) or more of the voting interest in such corporation or other entity; ii) fifty percent (50%) or more of the interest in the profit or income in the case of an entity other than a corporation; or iii) in the case of a partnership, control of the general partner. The name of each party appearing herein or in any Grant Program application shall be deemed to be the name of each such Affiliate of that party to the extent necessary to carry out the intent of this Agreement, and provided further that the performance of the obligations of any such Affiliate shall be deemed guaranteed by the party to this Agreement.

Information and Rules | Application Form

If you have any questions about the DNA Genotek Grant Program, please email grants@dnagenotek.com

 
"The collection protocol is very convenient, the extraction is very quick and simple, and the yield is great. Our downstream applications include PCR, restriction enzyme digestion and sequencing. We have collected numerous family members who were not willing to go for a blood draw, as well as children, elderly patients and overseas relatives. The ease of shipping and self-collection are remarkable. Our lab is very impressed with this timely product."

Ruth McPherson, MD, PhD
Nihan Kavaslar, PhD
Lipoproteins and Atherosclerosis Research Group
University of Ottawa Heart Institute
© 2012 DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc., all rights reserved.